Renal Business Today

Grafts

GORE Hybrid Vascular Graft Available in U.S.

FLAGSTAFF, Ariz.— W. L. Gore & Associates announced June 1 that its GORE Hybrid Vascular Graft is now commercially available in the United States. ...More
June 1, 2011
Posted in News, Business, Clinical & Pharma
ESRD Network 16 Reaches Fistula Benchmark

SEATTLE—The Northwest Renal Network (ESRD Network 16), said March 9 that it is the first ESRD Network in the United States to reach and surpass the benchmark of 66 percent arteriovenous (AV) fistula rate for prevalent dialysis patients. ...More
March 10, 2011
Posted in News, Clinical & Pharma, Practice Management
Gore Receives CE Mark for Hemodialysis Vascular Graft

FLAGSTAFF, Ariz.—The Gore Propaten Vascular Graft for hemodialysis access has received the CE Mark, according to W. L. Gore & Associates. ...More
February 22, 2011
Posted in News, Business, Government & Regulation
NephRx Starts Phase I Trial of Transplant Drug

KALAMAZOO, Mich.—NephRx Corp. announced Nov. 11 that it has started a phase I clinical trial of its transplant drug NX001 and has successfully dosed the first subject in the study. ...More
November 11, 2010
Posted in News, Clinical & Pharma
Obesity Increases Kidney Donation Complications

BERKSHIRE, U.K.—Patients who have received a new kidney are significantly more likely to develop transplant renal artery stenosis (TRAS) if they are obese or over 50, according to research published in the September issue of the Journal of Renal Care. ...More
September 8, 2010
Posted in News, Clinical & Pharma
NephRx Receives Orphan Drug Designation for Transplant Drug

KALAMAZOO, Mich.—The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to NephRx Corporation’s lead product NX001 for the prevention of delayed graft function (DGF) in renal transplant recipients. ...More
August 19, 2010
Posted in News, Clinical & Pharma
First Patient Receives Vascular Access Graft in Study

FLAGSTAFF, Ariz.—The first patient in a clinical study evaluating the self sealing Gore Acuseal Vascular Graft in patients on hemodialysis has been surgically implanted with the device, according to W. L. Gore & Associates. ...More
August 13, 2010
Posted in News, Clinical & Pharma
Aspirin, Anti-Clotting Drug Combo Lowers Dialysis Access Failure

WASHINGTON—The combination of aspirin and an anti-clotting drug reduces risk of dialysis access failure, according to a study in the May 21 issue of the New England Journal of Medicine. ...More
May 21, 2009
Posted in News, Clinical & Pharma
Grafts Grown from Tissue of Dialysis Patients

PARIS—Dialysis patients have been successfully fitted with blood vessels engineered solely from their own living tissue, according to a study published in The Lancet. ...More
April 29, 2009
Posted in News, Business, Clinical & Pharma, Practice Management
Spotlight: Vascular Surgery Associates

Albert Sam, MD, FACS, described the practice he is a surgeon at as more than just a vascular access center. “In fact, we are a contemporary vascular surgery practice,” he said. Baton Rouge, La.-based Vascular Surgery Associates has four board-certified vascular surgeons who ...More
November 30, 2007
Posted in Articles, Clinical & Pharma

featured links

HOT TOPICS

Computers & Software	Consulting, Management...
Equipment & Services	Hemodialysis Supplies
Patient Services	More Options...

Grafts

Mobile Health Snaps

Galleries

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail